Innate Pharma Announces Its Participation in H.C. Wainwright and Wolfe Research Healthcare Conferences
MARSEILLE, France--(BUSINESS WIRE)--Regulatory News:
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (' Innate ' or the ' Company ') today announced that members of its executive team will participate in the upcoming investor conferences, detailed below.
H.C. Wainwright 3 rd Annual Immune Cell Engager Virtual Conference
Dates: June 24, 2025 | Virtual
Wolfe Research Virtual Biotech Day
Dates: June 26, 2025 | Virtual
About Innate Pharma
Innate Pharma S.A. is a global, clinical-stage biotechnology company developing immunotherapies for cancer patients. Its innovative approach aims to harness the innate immune system through three therapeutic approaches: multi-specific NK Cell Engagers via its ANKET ® (A ntibody-based NK cell E ngager T herapeutics) proprietary platform and Antibody Drug Conjugates (ADC) and monoclonal antibodies (mAbs).
Innate's portfolio includes several ANKET ® drug candidates to address multiple tumor types as well as IPH4502, a differentiated ADC in development in solid tumors. In addition, anti-KIR3DL2 mAb lacutamab is developed in advanced form of cutaneous T cell lymphomas and peripheral T cell lymphomas, and anti-NKG2A mAb monalizumab is developed with AstraZeneca in non-small cell lung cancer.
Innate Pharma is a trusted partner to biopharmaceutical companies such as Sanofi and AstraZeneca, as well as leading research institutions, to accelerate innovation, research and development for the benefit of patients.
Headquartered in Marseille, France with a US office in Rockville, MD, Innate Pharma is listed on Euronext Paris and Nasdaq in the US.
Learn more about Innate Pharma at www.innate-pharma.com and follow us on LinkedIn and X.
Information about Innate Pharma shares
Disclaimer on forward-looking information and risk factors
This press release contains certain forward-looking statements, including those within the meaning of applicable securities laws, including the Private Securities Litigation Reform Act of 1995. The use of certain words, including 'anticipate,' 'believe,' 'can,' 'could,' 'estimate,' 'expect,' 'may,' 'might,' 'potential,' 'intend,' 'should,' 'will,' or the negative of these and similar expressions, is intended to identify forward-looking statements. Although the Company believes its expectations are based on reasonable assumptions, these forward-looking statements are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those anticipated. These risks and uncertainties include, among other things, the uncertainties inherent in research and development, including related to safety, progression of and results from its ongoing and planned clinical trials and preclinical studies, review and approvals by regulatory authorities of its product candidates, the Company's reliance on third parties to manufacture its product candidates, the Company's commercialization efforts and the Company's continued ability to raise capital to fund its development. For an additional discussion of risks and uncertainties, which could cause the Company's actual results, financial condition, performance or achievements to differ from those contained in the forward-looking statements, please refer to the Risk Factors ('Facteurs de Risque") section of the Universal Registration Document filed with the French Financial Markets Authority ('AMF'), which is available on the AMF website http://www.amf-france.org or on Innate Pharma's website, and public filings and reports filed with the U.S. Securities and Exchange Commission ('SEC'), including the Company's Annual Report on Form 20-F for the year ended December 31, 2024, and subsequent filings and reports filed with the AMF or SEC, or otherwise made public by the Company. References to the Company's website and the AMF website are included for information only and the content contained therein, or that can be accessed through them, are not incorporated by reference into, and do not constitute a part of, this press release.
In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by the Company or any other person that the Company will achieve its objectives and plans in any specified time frame or at all. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
This press release and the information contained herein do not constitute an offer to sell or a solicitation of an offer to buy or subscribe to shares in Innate Pharma in any country.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
A Unique Event for the S&P 500 Just Occurred -- Its 6th Time in 75 Years -- and It Has a 100% Success Rate of Forecasting Future Stock Returns
Though no asset class can match the average annual return of stocks over the long run, getting from Point A to B can be a wild ride. Stock market volatility is unlikely to taper anytime soon. An exceptionally rare outperformance for the broad-based S&P 500 should put a big smile on the faces of optimistic long-term investors. 10 stocks we like better than S&P 500 Index › Investors have a lot of ways to grow their wealth, including acquiring real estate, purchasing Treasury or corporate bonds, and buying commodities like gold, silver, and oil. While all of these investment channels have increased the nominal wealth of investors over the long run, none has held a candle to the annualized return of stocks over the last century. Although Wall Street's major stocks indexes -- the Dow Jones Industrial Average (DJINDICES: ^DJI), S&P 500 (SNPINDEX: ^GSPC), and Nasdaq Composite (NASDAQINDEX: ^IXIC) -- have a knack for increasing in value over long periods, they can deliver roller-coaster volatility over shorter timelines. For example, shortly after the benchmark S&P 500 hit its record-closing high on Feb. 19, the Dow Jones and S&P 500 would fall into correction territory within a matter of weeks. Volatility was even more pronounced in the growth-fueled Nasdaq Composite, which officially fell into a bear market in April. But volatility tends to beget opportunity on Wall Street. While the S&P 500 was enduring its fifth-steepest two-day percentage decline in early April, it was, in hindsight, setting up for a unique event that's historically had an exemplary track record of forecasting future stock returns. Although the stock market's premier measure of volatility, the CBOE Volatility Index, has plummeted from its recent high at the fastest pace in history, there's little reason to believe the catalysts that whipsawed Wall Street in March and April are going away anytime soon. For example, the aforementioned two-day swoon in the S&P 500 that cost the index 10.5% of its value was precipitated by President Donald Trump introducing his tariff and trade policy. Following the close of trading on April 2, the president announced a 10% sweeping global tariff along with higher "reciprocal tariff rates" for a few dozen countries that have historically maintained adverse trade imbalances with America. To be upfront, the terms of this initial unveiling have changed quite a bit. On April 9, Trump placed a 90-day pause of all reciprocal tariffs save for China. Roughly a month later, the U.S. and China agreed to reduce many of their reciprocal tariffs for a period of 90 days. Nevertheless, Wall Street craves consistency and predictability, and it's getting nothing of the sort from the current administration. The bigger concern is what might happen if Trump's tariff and trade policy sticks over a longer period (e.g., during a majority of his four-year term). Tariffs run the risk of worsening trade relations (even with allies), as well as increasing the prevailing rate of inflation domestically. While some businesses may choose to eat some or all of the tariff costs, these expenses can also get passed along to consumers. There's also been concern about how the bond market has responded in recent months. Although the Federal Reserve is currently in a drawn-out rate-easing cycle, and that would normally lead to Treasury bond yields declining or flattening out, the closely watched 10-year Treasury yield has been climbing. The 10-year Treasury yield is typically viewed as the benchmark for long-term interest rates. If the 10-year yield is climbing, it means mortgage rates are likely to rise, as well. Further, it signals an expectation that the prevailing rate of inflation is going to pick back up, which is a worrisome scenario with the Fed still early in its rate-easing cycle. Long story short, there are some clear concerns about the health of the U.S. economy. The other troublesome factor that isn't going away anytime soon is Wall Street's nosebleed valuation premium. Even taking into consideration that "value" is a subjective term that's going to be different for every investor, the S&P 500's Shiller price-to-earnings (P/E) Ratio (also known as the cyclically adjusted P/E Ratio, or CAPE Ratio) leaves no wiggle room -- we're witnessing one of the most-expensive stock markets in history. In December, the Shiller P/E Ratio closed at a peak of 38.89, which represents the third-highest multiple in a continuous bull market dating back to January 1871. With the Shiller P/E recently topping 37, the historic priciness of stocks is likely to keep things volatile. But a little over one week ago, Wall Street's benchmark stock index, the S&P 500, did something that's only been recorded six times over the last 75 years. Historically speaking, when this event has occurred, it's been a surefire bull signal for investors. As you've probably noticed, stocks have bounced back in a meaningful way since the initial tariff-related swoon that took the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite to their lows for the year on April 8. However, you might not realize just how strong this rally in equities has been. Over a two-month period, ended June 9, 2025, the S&P 500 gained 20.8%. This tied for the fifth-biggest two-month percentage gain in the S&P 500 since 1950 and marked only the sixth time in 75 years that the index had gained at least 20% over a two-month time frame. What's worthwhile is examining how the S&P 500 performed in various periods following these extremely rare instances where it logged a 20%-plus percentage gain over two months. Based on data compiled by Carson Group's Chief Market Strategist Ryan Detrick, the S&P 500 was higher at every single time interval (one, three, six, and 12 months) following a two-month advance of at least 20%. What's even more impressive than this correlation (thus far) having a 100% success rate of forecasting future upside is just how far outside the historical norm the benchmark index climbed over the next 12 months following these unique events. Whereas the S&P 500 has averaged a 9.2% annual return since 1950, it's delivered an average (I repeat, average) return of 30.8% following the five prior instances where it achieved a 20%-plus two-month return. Based solely on this correlation, it would appear stocks are being given a green light to skyrocket higher. This is a good time to mention that just because something has worked in the past via a correlation, it doesn't guarantee it'll work in the future. Nevertheless, a 100% correlation rate with an average 12-month return of 30.8% would appear to offer a better than 50-50 chance of the bulls being right. What Ryan Detrick's data set also demonstrates is that emotion-driven volatility and fear tend to offer great investment opportunities on Wall Street. Even though we're never going to know ahead of time precisely when these elevator-down moves will begin, how long they'll last, or how steep the ultimate decline will be, we do have copious statistical data that shows just how disproportionate bull and bear markets actually are. Two years ago, the researchers at Bespoke Investment Group published a data set on X that openly compared and calculated the calendar-day length of every bull and bear market for the S&P 500 dating back to the start of the Great Depression in September 1929. Whereas the typical bear market resolved in 286 calendar days (about 9.5 months), the average bull market stuck around for 1,011 calendar days (approximately two years and nine months). Wagering on the stock market to bounce back after emotion-driven moves lower has historically been a genius move. Before you buy stock in S&P 500 Index, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and S&P 500 Index wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,702!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $870,207!* Now, it's worth noting Stock Advisor's total average return is 988% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Sean Williams has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. A Unique Event for the S&P 500 Just Occurred -- Its 6th Time in 75 Years -- and It Has a 100% Success Rate of Forecasting Future Stock Returns was originally published by The Motley Fool
Yahoo
2 hours ago
- Yahoo
Mizuho remains bullish on data centers; DLR remains top pick
-- Analysts at Mizuho Securities remain bullish on data center REITs, reaffirming Digital Realty Trust (NYSE:DLR) as their top pick while raising price targets following first-quarter earnings updates. Despite recent outperformance, the analysts note that the sector continues to capitalize on strong bookings and ongoing demand from hyperscale customers. Digital Realty shares now trade at 27 times adjusted funds from operations (AFFO), representing a 30% premium to the broader REIT group. While some bears may argue 'good news' is already priced in, Mizuho's team sees multiple catalysts ahead. The firm lifted its price target on the stock to $191 from $177, applying a 27x AFFO multiple to its estimates for fiscal year 2026 (FY26). New FFO forecasts stand at $7.13 for 2025 and $7.63 for 2026, with estimates modestly above consensus for 2025. For Equinix (NASDAQ:EQIX), another key player in the data center space, Mizuho raised its price target to $1,069 from $1,053, reflecting updated FFO estimates of $38.08 and $41.12 for 2025 and 2026, respectively. Mizuho's outlook for Digital Realty incorporates several key drivers. The analysts model strong rent spreads of 6% and 7% in 2025 and 2026, alongside occupancy gains of 170 and 200 basis points, respectively. They also point to upside potential in the company's 0-1MW segment, noting management conversations that suggest a path to doubling revenue in that category by mid-to-late FY26. 'On average, the company has booked about $50mm in revenue in the last two years and a broad goal is to get to a quarterly run-rate of $100mm,' the analysts said. 'Our conversations with management suggest there is a path to that level during the next 2-3 years.' 'Theoretically, at a 50% margin, a $400mm run-rate, this could add 1-2% growth to the bottom line,' they added. Mizuho views the recently formed investment fund as a significant growth lever. The analysts believe the fund 'could become much larger than the current estimate of $10bn to potentially match or exceed other large REIT funds.' They see benefits over traditional joint ventures, including 'a more favorable fee structure and greater control over the assets/transactions and mitigating the risk of scaling the development pipeline.' Mizuho also expects the fund structure to enable Digital Realty to recycle stabilized assets into the fund at attractive cap rates while allocating capital toward higher-growth projects. Depending on when the fund closes, likely by year-end 2025, overall FFO could increase by 3 to 5 cents, according to the note. On valuation, despite higher multiples relative to historical levels, Mizuho argues the stock premium is justified given strong bookings and the additional upside potential from the fund. Related articles Mizuho remains bullish on data centers; DLR remains top pick Analysts start with bullish ratings on Hinge Health on growth potential UBS starts coverage on packaged food stocks with cautious tone, Sell on Freshpet
Yahoo
2 hours ago
- Yahoo
Digital Turbine Inc (APPS) Q4 2025 Earnings Call Highlights: Strong EBITDA Growth Amid Revenue ...
Revenue: $119.2 million for the fiscal fourth quarter, representing 6% growth year over year. EBITDA: $20.5 million for the fiscal fourth quarter, a 66% increase year over year. Non-GAAP Earnings Per Share: $0.10 for the fiscal fourth quarter. Free Cash Flow: $5.5 million in the fiscal fourth quarter, an increase of over $21 million compared to the prior year period. Non-GAAP Gross Margin: 48% in the fiscal fourth quarter, up from 46% in the previous year. Cash Operating Expenses: $36.1 million in the fiscal fourth quarter, a 7% decline year over year. GAAP Net Loss: $18.8 million or $0.18 per share for the fiscal fourth quarter. Non-GAAP Net Income: $10.1 million or $0.10 per share for the fiscal fourth quarter. Full Fiscal Year 2025 Revenue: $490.5 million, a 10% decline from the previous year. Full Fiscal Year 2025 EBITDA: $72.3 million, compared to $92.4 million in the previous year. Cash Balance: $40.1 million at the end of the fiscal fourth quarter. Debt Balance: $408.7 million at the end of the fiscal fourth quarter. Fiscal Year 2026 Revenue Outlook: Expected to be between $515 million and $525 million. Fiscal Year 2026 Adjusted EBITDA Outlook: Projected to be between $85 million and $95 million. Warning! GuruFocus has detected 6 Warning Signs with APPS. Release Date: June 16, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Digital Turbine Inc (NASDAQ:APPS) returned to year-over-year growth in both revenue and EBITDA, with EBITDA growing by 66%. The company extended its credit facility, which is expected to lower the cost of capital in the future. Revenue per device (RPD) increased significantly, with a 40% rise in the US and over 100% internationally, driven by strong advertiser demand. The company has made significant strides in leveraging first-party data and AI machine learning, leading to improved conversion rates. Digital Turbine Inc (NASDAQ:APPS) has expanded its device footprint and product portfolio, including the launch of a new version of Ignite on over 100 million devices. The AGP segment experienced a 3% year-over-year decline in revenue. The company reported a GAAP net loss of $18.8 million for the fiscal fourth quarter. Total revenue for the full fiscal year 2025 declined by approximately 10% compared to the previous year. The company has a significant debt balance of $408.7 million at the end of the quarter. Despite improvements, the company still faces challenges in optimizing expenses and achieving further efficiencies. Q: Can you discuss the significant increase in Revenue Per Device (RPD) internationally and the opportunities you're seeing? Are these with new device makers, new carriers, or both? A: William Stone, CEO: The increase in international RPD is due to several factors. We've expanded our international demand, improved operational execution in markets like Brazil, India, and the UK, and increased our distribution footprint. This has allowed us to attract more partners, such as Motorola and Telefonica, enhancing our supply density and driving improved results. Q: With the favorable regulatory environment, have you seen increased interest from app publishers in your SingleTap or AppInstall technology? Can you share the number of new licensees signed last quarter? A: William Stone, CEO: The regulatory environment is indeed favorable, promoting a level playing field for publishers. This has increased interest in our SingleTap licensing capabilities. We've partnered with companies like Epic and Pinterest, and there's growing interest in leveraging our device footprint and data for scalable consumer reach. Q: Regarding operating expenses, given the strong adjusted EBITDA, do you expect significant changes in expense levels going forward? A: Stephen Lasher, CFO: We expect operating expenses to remain relatively flat. While there may be slight increases as the business grows, the overall expense level should remain stable. Q: What are the key drivers for your future growth strategy? A: William Stone, CEO: Our growth strategy focuses on expanding our device footprint, enhancing product portfolios, and building deeper media relationships. Key initiatives include launching new versions of Ignite, leveraging first-party data with AI, and expanding alternative app efforts. We aim to drive growth through increased efficiency and automation. Q: Can you elaborate on the strategic investments in your AGP business and how they differentiate you from competitors? A: William Stone, CEO: Our AGP business focuses on leveraging first-party data to attract brands seeking digital channels beyond CTV or retail media. We've invested in building a moat with high barriers to entry, earning trust from top brands and agencies. Our efforts in performance advertising and supply diversification are key differentiators. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
